WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'5101 Infant (under 12 months) mortality rate: 332
GDP / capita (US$): 15'8071 Child (under 5 years) mortality rate: 412

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 2'292  2'250  2'209  2'169  2'129  1'728  1'378  1'001 
Births 53  53  53  53  53  48  47  44 
Surviving infants 52  52  52  52  51  44  44  41 
Pop. less than 5 years 260  259  256  252  248  221  216  188 
Pop. less than 15 years 720  712  702  694  686  650  612  467 
Female 15-49 years 635  623  613  601  590  460  325  231 

Number of reported cases

(Click for retrospective incidence data for Botswana)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  2'672  1'218  4'091 
Mumps
ChartChart
 
Pertussis
ChartChart
  22  110 
Polio*
ChartChart
 
Rubella
ChartChart
  25  508  121  170 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Botswana)
Vaccine year result method % card seen                                                
BCG 2012  99  EPI   97  73  90  78  93  99*  73 
DTP1 2012  98  EPI   97  79  99  87  99  99*  94 
DTP3 2012  95  EPI   97  75  85  80  94  79  85 
DTP4         
IPV1          80  49  51 
HepB_BD          76  91  99*  86 
HepB3 2012  95  EPI   97  75  85  80  94  73 
Hib3 2012  95  EPI   97  75  85  80  94 
JapEnc         
MCV1          73  90  77  93  93  84 
MCV2          96  74  70  85  82 
MenA         
PCV1          84  99  86  99  99* 
PCV2          71  86  78  91  83 
PCV3          75  83  71  81  65 
Pol3 2012  97  EPI   97  75  85  74  86  86  85 
Rota1          77  90  82  98  96 
RotaC          72  77  70  82  78 
RCV1          73  90 
TT2plus 2012  55  EPI   97  57  52  53  52  70  45 
PAB          70 
VAD1          86  75  84  97  79 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Botswana)
BCG
ChartChart
  98  98  98  98  99  93  92 
DTP1
ChartChart
  98  98  98  98  98  99  89 
DTP3
ChartChart
  95  95  95  95  97  92  71 
HepB3
ChartChart
  95  95  95  95  86 
HepB_BD
ChartChart
 
Hib3
ChartChart
  95  95  95  95 
IPV1
 
MCV1
ChartChart
  97  97  97  97  91  87  63 
MCV2
ChartChart
  80  80  85  83 
PCV3
ChartChart
  95  95  95  72 
Pol3
ChartChart
  96  96  96  96  97  90  46 
RCV1
ChartChart
 
RotaC
ChartChart
  95  95  95  85 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 24  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 21
From 80 to 89% 21
From 50 to 79% 58
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 18 months; 7 years; Yes children and pupils in standard 1 respectively
DTwPHibHepB 2, 3, 4 months; Yes
HepB_Adult Yes HCWs
HepB_Pediatric birth; Yes
HPV 1st contact, +6 months; Yes standard 5 girls aged 9-13 years
IPV 4 months; Yes
MR 9, 18 months; Yes 9-24 months
OPV 2, 3, 4, 18 months; 7 years; Yes
Pneumo_conj 2, 3, 4 months; Yes
Rotavirus 2, 3 months; Yes
Td from August 2018
TT 1st contact pregnancy; +4 weeks; +6 months; +1, +1 year; Yes pregnant women and WCBA
VitaminA 6-59 months (x2); Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2022  2012-2016  2012-2016  2012-2016  2012-2016  2011-2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 24  24  24  24  24  24  24 

System performance

Total Nº districts in country number 24  24  24  24  24  24  24 
Nº districts with DTP3 coverage >=80% number 10  19  12  19  14  18  17 
% of districts with DTP3 coverage >=80% From 0 to 100% 42  79  50  79  58  75  71 
Nº districts with measles (MCV1) coverage >=95% number 10  14  12  16  16 
% of districts with MCV1 coverage >=95% From 0 to 100% 13  42  17  58  50  67  67 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes  No  No    No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 99  98  100  97  100    98 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.